Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Association of Carboxylesterase 1 Gene (CES1) Polymorphism with Weight loss in Children with Attention Deficit Hyperactivity Disorder during Methylphenidate Treatment

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Duffy-null genotype and risk of infection

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Birth with Synthetic Oxytocin and Risk of Childhood Emotional Disorders: A Danish Population-based Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Psychotic experiences from preadolescence to adolescence: when should we be worried about adolescent risk behaviors?

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Reappraisal is an effective emotion regulation strategy in children with Tourette syndrome and ADHD

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Children with Attention Deficit Hyperactivity Disorder (ADHD) show large variations in response to methylphenidate (MPH) treatment, which may result from genetic factors associated with MPH metabolism. We aimed at investigating a possible link between the -75 T>G polymorphism in the 5’ untranslated region of the gene coding for carboxylesterase 1 (CES1) and a common adverse effect, weight loss, during the first three months of MPH treatment. We analyzed the association between a CES1 polymorphism and longitudinal clinical data based on retrospective analysis of medical records, from first to last recorded visit at the clinic. By use of poly chain reaction and the Sanger method we genotyped the -75 T>G gene polymorphism and examined the association to clinical response, which was based on retrospective analysis of longitudinal clinical data from medical records. The primary clinical outcome measure was weight loss during the first 3 months of MPH treatment. Data from 74 MPH treated children with ADHD, mean age 8.6 years, 57% males, were analysed. There were n=26 G-carriers (heterozygote TG and homozygote GG) and n=48 TT-homozygotes. The proportion of weight loss and mean weight change differed significantly in G-carriers (88% / -0.279 kg) compared with TT-homozygotes (31% / +0.157 kg). This study shows an association between the -75 T>G polymorphism in CES1 and MPH treatment response, demonstrated by a significantly higher frequency and extent of weight loss in G-carriers compared to TT-homozygotes.
Original languageEnglish
Article number1010
JournalSM Journal of Bioinformatics and Proteomics
Volume2
Issue number1
Pages (from-to)1-8
Number of pages8
Publication statusPublished - 21 Mar 2017

ID: 51534290